What's Going On With Bon Natural Life Stock Friday?

Zinger Key Points

Bon Natural Life Limited BON stock is moving higher on Friday after the company announced it won a $12 million supply agreement to co-develop apple polyphenol-infused health solutions.

What To Know: Bon won a 24-month long supply agreement to co-develop the aforementioned health solutions for Shanghai Yunsheng, a Chinese functional ingredients distributor.

The partnership will leverage Bon’s patented extraction technology to deliver formulations that combine antioxidant-rich apple polyphenols with plant-based proteins.

“As one of the world’s premier apple polyphenol suppliers, we’re leveraging our vertically integrated supply chain to dominate this high-growth niche,” said Yongwei Hu, Chairman and CEO of Bon.

Bon shares are trading on unusually high volume, with 285.79 million shares exchanged. The company's 100-day average is 15.27 million, according to data from Benzinga Pro.

See Also: Are Chinese Tech Stocks At A ‘Serious Risk’ Amid Escalating Trade War? ‘Delisting Is Moving Up In The List Of Retaliatory Options,’ Says Analyst

BON Price Action: At the time of writing, Bon shares are trading 55.1% higher at 9 cents, per data from Benzinga Pro.

Image: This illustration was generated using artificial intelligence via Midjourney.

Loading...
Loading...
BON Logo
BONBon Natural Life Ltd
$0.081525.4%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
0.43
Growth
-
Quality
-
Value
99.68
Price Trend
Short
Medium
Long
Got Questions? Ask
Which health solution companies will benefit from this deal?
How might Bon Natural Life's growth impact competitors?
What opportunities exist in the functional ingredients market?
Are Chinese distributors looking for more partnerships?
Which investors are focused on health solutions?
How could apple polyphenol demand affect suppliers?
What are the implications for plant-based protein producers?
Is there potential for biotechnology investments in this sector?
What trends are shaping the nutraceutical market currently?
How will high trading volume affect Bon's stock price?
Market News and Data brought to you by Benzinga APIs

Posted In:
Comments
Loading...